Depression And Seasonal Affective Disorder Therapeutics Market

Future Market Insights

Key Insight

Depression and seasonal affective disorder therapeutics sales will expand through 2035, with SSRIs at 30.2% of drug type demand and hospital pharmacies at 55.1% of distribution channel sales in 2025. The market was valued at USD 6.2 billion in 2025 and is forecast to record a 3.9% CAGR between 2025 and 2035.

October 09, 2025

Anurag Sharma

250 Pages

Cite this Report

Depression And Seasonal Affective Disorder Therapeutics Market

https://www.futuremarketinsights.com/reports/depression-and-seasonal-affective-disorder-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Biogen Idec
Bristol-Myers Sqibb
Eli Lilly and Company
GSK
Janssen Pharmaceutical Inc
Merck KGaA
The Vanguard Group
L'Oréal

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Depression And Seasonal Affective Disorder Therapeutics Market

Key Players

Similar Industry Reports